Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Real-world effectiveness of once-weekly glucagon-like peptide-1 receptor agonists (OW GLP-1RAs) in comparison with dipeptidyl peptidase-4 inhibitors (DPP-4is) for glycemic control and weight outcomes in type 2 diabetes mellitus (RELATE)
Andrea Truini received consulting fees and payment for lectures from the Sigma-Tau of Alfasigma Group, Angelini, Gruenenthal, and Pfizer
United States Renal Data System 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States
It may help you feel more focused and less distracted
Its being discussed by FDA is not a substitute for data
Get it right, and you'll know whether to persist or pause
)
US$ 21.33
US$ 28.99
US$ 25.07
US$ 24.85
US$ 22.43
US$ 25.37
